Skip to main
STTK

Shattuck Labs (STTK) Stock Forecast & Price Target

Shattuck Labs (STTK) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Shattuck Labs is a biotechnology company with a strong financial position and promising drug pipeline. Their lead drug, SL-325, has shown a differentiated safety profile and superior blockade of inflammatory signaling, with a completion date for its clinical trial set in 2029. With potential for multiple indications and targeting of DR3, Shattuck Labs could be an appealing acquisition target for the future.

Bears say

Shattuck Labs is facing stiff competition and potential funding issues, which could slow down the development of their TL1A therapy. The expertise of the company's leadership is a positive factor, but ultimately, the success of their pipeline drugs will determine the stock's performance. With a projected price target of $15 based on risk-adjusted net present value analysis, there is not enough upside potential for investors to have a positive outlook on the stock.

Shattuck Labs (STTK) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Shattuck Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Shattuck Labs (STTK) Forecast

Analysts have given Shattuck Labs (STTK) a Buy based on their latest research and market trends.

According to 5 analysts, Shattuck Labs (STTK) has a Buy consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Shattuck Labs (STTK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.